First Trust Nasdaq Pharmaceuticals ETF Rating $24.39 -0.14 (-0.57%) Closing price 03:54 PM EasternExtended Trading$24.38 0.00 (-0.02%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock First Trust Nasdaq Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FTXH Aggregate RatingModerate Buy 2.62Holdings in FTXH have an aggregate rating of Moderate Buy based on 755 analyst ratings issued in the past year covering 50 companies (100.0% of the portfolio).FTXH Aggregate Price Target$24.39High Prediction$24.39Average Prediction$24.39Low Prediction$24.39Holdings in FTXH have an aggregate price target of $24.39 and a range of $24.39 to $24.39 covering 50 companies (100.0% of the portfolio).FTXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy13 Buy rating(s)Moderate Buy26 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Nasdaq Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 FTXH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.52%BMYBristol-Myers Squibb$49.98-2.7%4.7374 of 5 stars2.32$57.67 15.4%19Short Interest ↓Positive News7.51%JNJJohnson & Johnson$153.66-0.5%4.7814 of 5 stars2.61$171.50 11.6%18Earnings ReportDividend IncreaseAnalyst ForecastShort Interest ↓7.48%ABBVAbbVie$176.84-0.4%4.9061 of 5 stars2.85$210.71 19.2%267.26%MRKMerck & Co., Inc.$78.28-1.1%4.9993 of 5 stars2.64$115.50 47.5%227.13%PFEPfizer$22.45+1.5%4.9971 of 5 stars2.59$31.07 38.4%17News Coverage3.90%AMGNAmgen$295.30+0.5%4.2742 of 5 stars2.48$314.91 6.6%23Analyst ForecastNews Coverage3.81%GILDGilead Sciences$105.68-0.8%4.5397 of 5 stars2.72$105.12 -0.5%29Positive News3.72%UTHRUnited Therapeutics$284.82+0.2%4.9046 of 5 stars2.67$388.25 36.3%12Positive News3.70%ZTSZoetis$149.15-1.1%4.5815 of 5 stars3.08$214.40 43.7%12Analyst ForecastPositive News3.61%BIIBBiogen$116.98-1.9%4.6947 of 5 stars2.42$213.15 82.2%31Analyst Revision3.43%VTRSViatris$7.48-2.0%2.963 of 5 stars1.75$10.50 40.4%43.39%REGNRegeneron Pharmaceuticals$557.91-2.3%4.8717 of 5 stars2.77$964.88 72.9%26Analyst ForecastPositive News3.32%LLYEli Lilly and Company$756.55+0.3%4.9182 of 5 stars2.89$1,012.00 33.8%19Analyst ForecastAnalyst Revision3.26%JAZZJazz Pharmaceuticals$102.91+1.1%4.8874 of 5 stars2.93$187.71 82.4%142.72%OGNOrganon & Co.$11.07-2.1%4.7612 of 5 stars2.43$20.60 86.2%7Short Interest ↓1.94%EXELExelixis$36.54+2.2%4.2574 of 5 stars2.50$37.59 2.9%20Positive NewsGap Down1.90%CRLCharles River Laboratories International$106.02-0.5%4.7683 of 5 stars1.94$182.00 71.7%16Short Interest ↓Analyst RevisionNews CoverageHigh Trading Volume1.79%MEDPMedpace$305.00-0.1%4.4364 of 5 stars2.31$357.50 17.2%13Upcoming EarningsAnalyst DowngradeNews Coverage1.55%ILMNIllumina$74.59-0.6%4.6601 of 5 stars2.48$138.70 85.9%21News Coverage1.54%ELANElanco Animal Health$8.24-5.0%4.3682 of 5 stars2.43$14.67 77.9%7Analyst ForecastNews Coverage1.52%HALOHalozyme Therapeutics$61.28-0.2%4.3969 of 5 stars2.60$62.78 2.4%10Positive News1.29%BMRNBioMarin Pharmaceutical$60.02+0.6%4.8868 of 5 stars2.71$94.00 56.6%241.26%NBIXNeurocrine Biosciences$96.16+1.3%4.8451 of 5 stars2.91$161.86 68.3%23Analyst UpgradeNews CoveragePositive NewsGap Up1.10%ALKSAlkermes$27.94+1.5%4.7296 of 5 stars2.67$38.50 37.8%12Short Interest ↓Analyst RevisionPositive News0.95%PRGOPerrigo$25.04+0.2%4.8824 of 5 stars2.25$33.00 31.8%4News CoveragePositive NewsGap Down0.81%AMRXAmneal Pharmaceuticals$7.17-0.6%3.2131 of 5 stars3.00$10.80 50.6%5Short Interest ↑Positive News0.80%PBHPrestige Consumer Healthcare$80.90-1.5%4.1674 of 5 stars2.50$93.33 15.4%6News CoveragePositive News0.77%CPRXCatalyst Pharmaceuticals$23.23+1.9%4.6112 of 5 stars3.13$32.29 39.0%8Positive News0.70%TGTXTG Therapeutics$39.03+1.6%3.3135 of 5 stars2.83$40.67 4.2%6Positive News0.70%CORTCorcept Therapeutics$69.59+3.2%4.3974 of 5 stars3.00$143.25 105.8%5Insider TradePositive News0.63%ADMAADMA Biologics$22.15+5.9%1.8772 of 5 stars3.25$22.50 1.6%4Options VolumeNews CoveragePositive NewsGap Up0.57%CAHCardinal Health$134.25-0.4%4.6285 of 5 stars2.71$140.86 4.9%14Short Interest ↓Positive News0.57%ALNYAlnylam Pharmaceuticals$230.93-3.8%4.5122 of 5 stars2.77$315.58 36.7%260.54%VRTXVertex Pharmaceuticals$500.49+0.9%4.1034 of 5 stars2.64$512.41 2.4%25Short Interest ↓Analyst RevisionPositive News0.53%GHGuardant Health$44.85-0.7%3.6829 of 5 stars3.05$49.00 9.3%21Positive NewsGap Down0.53%KRYSKrystal Biotech$169.13+0.1%4.6515 of 5 stars3.00$220.00 30.1%80.51%MDGLMadrigal Pharmaceuticals$321.10-0.4%4.0571 of 5 stars2.80$378.44 17.9%10News CoveragePositive News0.50%EXASExact Sciences$43.67-1.3%4.2311 of 5 stars2.95$69.25 58.6%22Positive NewsGap Down0.48%BPMCBlueprint Medicines$81.45-1.3%2.6187 of 5 stars2.70$124.95 53.4%23Positive News0.48%INSMInsmed$71.07+0.1%4.1206 of 5 stars3.00$94.00 32.3%16Positive News0.45%VCELVericel$42.02+1.9%2.4125 of 5 stars3.00$60.86 44.8%7News Coverage0.45%INCYIncyte$58.46-1.3%4.8343 of 5 stars2.21$74.88 28.1%190.45%PTCTPTC Therapeutics$46.94+4.1%3.8935 of 5 stars2.53$63.77 35.9%15Short Interest ↑Positive News0.45%AXSMAxsome Therapeutics$103.83+0.3%4.5288 of 5 stars3.00$169.80 63.5%16Analyst Revision0.44%AKROAkero Therapeutics$38.08+1.3%4.307 of 5 stars3.00$76.29 100.3%9Gap Down0.44%ACADACADIA Pharmaceuticals$14.99+0.9%4.0179 of 5 stars2.50$23.93 59.7%16Analyst RevisionNews Coverage0.44%VCYTVeracyte$31.76-1.2%4.0149 of 5 stars2.70$42.60 34.1%10Short Interest ↑Positive News0.42%SRRKScholar Rock$30.22+4.5%3.892 of 5 stars3.00$42.67 41.2%6Positive News0.40%SWTXSpringWorks Therapeutics$37.59+0.3%2.0536 of 5 stars3.00$73.20 94.7%5Positive News0.29%SRPTSarepta Therapeutics$54.42-0.4%4.6793 of 5 stars2.83$161.83 197.4%24Gap Up This page (NASDAQ:FTXH) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FTXH Stock Free FTXH Stock Alerts